CytoSorb® is CE-mark approved in the E.U. In the U.S., CytoSorb® and DrugSorb-ATR® are investigational devices not yet FDA authorized/approved/cleared.
Content dedicated only to Investor Relationsback to cytosorbents.com

Investor Relations

CytoSorbents

Events & Presentations

Recent and Upcoming Events

Past Events

CytoSorbents to Participate in a Virtual Fireside Chat with D. Boral Capital on Monday, December 15, 2025

Dec 15, 2025 12:00 am EST

Jefferies Global Healthcare Conference

Nov 18, 2025 12:00 am EST

CytoSorbents to attend the H.C. Wainwright 27th Annual Global Investment Conference

Sep 10, 2025 12:00 am EDT

CytoSorbents presents Turning the Tide in Sepsis and Septic Shock: Real World Insights with CytoSorb

Sep 10, 2025 12:00 am EDT

Cytosorbents to Participate in 10th Annual Needham Virtual MedTech & Diagnostics 1×1 Conference

Aug 11, 2025 12:00 am EDT